Torrent Pharmaceuticals Ltd

Stage 3 · Topping · week 1⚠ 2→3 today

As of 9 Oct 2026, Torrent Pharmaceuticals is in Stage 3 — topping, where an uptrend loses steam, in its first week (since 9 Oct 2026). It closed at ₹4,657, 9.1% below its 52-week high and above its 200-day average, which is rising. In Health Care, 44.6% of stocks are in Stage 2.

Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil,… More about the company

₹4,656.9
+0.86% today
₹1.77L Cr · Large cap
Market Neutral — FadingHealth Care 44.6% in Stage 2-2.6 pts / 20dPharmaceuticals 51.3%-0.4 pts

Pro read

Pro

Our read

Topping — the uptrend is tiring

Setup score

—

Momentum

Steady

Edge

—

Is TORNTPHARM early, or has it already run? Pro answers that for every NSE stock, after every close.

₹2,999 · 12 months₹1,999 · 6 months
Loading price chart…
vs 52W High
-9.1%
₹3,490.8 lo₹5,122.8 hi
9.1% below 52W high — weakening from peak
Stock is rolling over from its 52W high. Stage 3 distribution — new longs are high risk here.
Stage Maturity
Week 1
1w13w26w
Week 1 — early distribution
How long this stock has been in Stage 3 distribution. Longer tops often precede deeper Stage 4 declines.
vs 200 DMA
4.6%
200 DMA: ₹4,453.7 · rising
Stock is losing its 200 DMA. Once lost, it confirms Stage 4 risk. This is a major red flag for existing holders.
Rel Volume
0.85x
vs 50-day avg
Volume spikes on down days during Stage 3 signal distribution — institutions are exiting. A clear warning to avoid new longs.
Trend Health
↓
MA20 rolling over · -1.8% vs MA50 -0.6%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
1M
-6.1%
3M
-5.0%
6M
+15.6%
YTD
+22.7%
1Y
+31.4%
Sector
Health Care
↓ Peaking
Stage 2%
44.6%
20d Δ
-2.6pp
1M return
-4.9%
3M return
+0.2%
Sector Stage-2 % · last 20 days
Sector has 74 Stage 2 leaders. See Health Care Stage 2 →
Industry
Pharmaceuticals
→ Flat
Stage 2%
51.3%
20d Δ
-0.4pp
1M return
-4.2%
3M return
-0.6%
Industry Stage-2 % · last 20 days
Industry has 58 Stage 2 leaders. See Pharmaceuticals Stage 2 →
Stage Cycle Timeline2023-07-14 → 2026-10-09
S2 51w
S2 16w
S2 47w
2023-07-142026-10-09
S1S2S3S4Setup score (0–10, dashed line at 5)
S2 10w → S3 8w → S2 51w → S3 11w → S2 3w → S3 2w → S4 7w → S1 10w → S2 16w → S3 2w → S2 47w → S3 1w current
Total tracked: 168 weeks across 12 stage runs.
Scan Membership
Breakout Watch
Latest: 2025-11-17
3 appearances in last 60 days. First seen: 2025-01-28.
Stocks that stay in the scan for 13+ weeks are in the highest observed-return cohort — they keep qualifying because the structure remains intact, not by luck. Persistence in the scan is itself a quality signal.
Recent Stage Timeline
2026-10-09S32→3
Wk 1 · Vol 0.85x
2026-10-08S2
Wk 46 · Vol 0.62x
2026-10-07S2
Wk 46 · Vol 0.59x
2026-10-06S2
Wk 46 · Vol 0.74x
2026-10-05S2
Wk 45 · Vol 0.81x
2026-10-01S2
Wk 45 · Vol 0.88x
2026-09-30S2
Wk 45 · Vol 0.98x
2026-09-29S2
Wk 45 · Vol 1.77x
2026-09-28S2
Wk 45 · Vol 0.94x
2026-09-25S2
Wk 44 · Vol 0.74x
2026-09-24S2
Wk 44 · Vol 0.48x
2026-09-23S2
Wk 44 · Vol 0.57x
Sector Peers — Stage 2All →
BAFNAPH
wk 18 · 0.0% from hi
8.6
ZIMLAB
wk 22 · 0.0% from hi
8.3
KILITCH
wk 2 · -7.3% from hi
8.3
SMSPHARMA
wk 3 · -8.0% from hi
8.3
RPGLIFE
wk 16 · -12.0% from hi
7.6
Moving averages & range
50 DMA
₹4,910.1
200 DMA
₹4,453.7
52W High
₹5,122.8
52W Low
₹3,490.8
5D Low
₹4,617.1
Resistance levels (recent highs)
20d High
₹4,988.5
60d High
₹5,122.8
120d High
₹5,122.8
250d High
₹5,122.8
Next resistance
+7.1%
to 20d High
Ask the Market AI about TORNTPHARMAsk →
P/E (TTM)
70.8
Forward 48.2
Earnings Growth (YoY)
-21.8%
Revenue +41.8%
ROE
+17.0%
Profit margin +15.5%
Dividend Yield
0.85%
P/B 18.2
About this companyHealth Care· Pharmaceuticals

Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally. The company offers products in various therapeutic areas, including anti-diabetic, anti-microbial, cardiovascular, urology, gynecology, oncology, gastro-intestinal, nephrology, neuro-psychiatric, cosmo-dermatology, pain management, anti-infective, and miscellaneous, as well as vitamins, minerals, and nutrients. It also provides contract manufacturing services. The company offers its products under Tedibar, Shelcal, Unienzyme, and Ahaglow brands. The company was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. The company was founded in 1959 and is based in Ahmedabad, India. Torrent Pharmaceuticals Limited is a subsidiary of Torrent Investments Limited.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-09. Past data patterns are not indicative of future results. This page is a data analytics tool only.